Detalles de la búsqueda
1.
Tobacco in China.
Lancet
; 383(9934): 2045-2046, 2014 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-24931689
2.
MUC16: The Novel Target for Tumor Therapy / 中国肺癌杂志
Chinese Journal of Lung Cancer
; (12): 452-459, 2022.
Artículo
en Zh
| WPRIM | ID: wpr-939731
3.
Interpretation for Evidence-based Practice Guideline of Medication Therapy of High-dose Methotrexate in China / 中国药房
China Pharmacy
; (12): 2032-2039, 2022.
Artículo
en Zh
| WPRIM | ID: wpr-936985
4.
Progress of prognostic factors for Hodgkin lymphoma / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 185-189, 2021.
Artículo
en Zh
| WPRIM | ID: wpr-882260
5.
Tumor autoantibodies in the diagnosis and prognosis of prostate cancer / 中华检验医学杂志
Chinese Journal of Laboratory Medicine
; (12): 260-264, 2021.
Artículo
en Zh
| WPRIM | ID: wpr-885909
6.
Response of Lung Adenocarcinoma Harbouring Sensitizing EGFR Mutation to the Fourth-line Combination Treatment of Pembrolizumab and Anlotinib / 中国肺癌杂志
Chinese Journal of Lung Cancer
; (12): 739-742, 2021.
Artículo
en Zh
| WPRIM | ID: wpr-922241
7.
The diagnostic efficacy of FNA-Tg in detecting lymph node metastasis of differentiated thyroid cancer and its influencing factors / 中华检验医学杂志
Chinese Journal of Laboratory Medicine
; (12): 670-677, 2020.
Artículo
en Zh
| WPRIM | ID: wpr-871950
8.
Advances in Drug Resistance Mechanisms and Prognostic Markers of Targeted Therapy in ALK-positive Non-small Cell Lung Cancer / 中国肺癌杂志
Chinese Journal of Lung Cancer
; (12): 1014-1022, 2020.
Artículo
en Zh
| WPRIM | ID: wpr-880219
9.
The differential diagnosis of pulmonary infiltrates in cancer patients during the outbreak of the 2019 novel coronavirus disease / 中华肿瘤杂志
Chinese Journal of Oncology
; (12): E008-E008, 2020.
Artículo
en Zh
| WPRIM | ID: wpr-811681
10.
The clinical trials of China innovative new anti-cancer drugs / 中华肿瘤杂志
Chinese Journal of Oncology
; (12): 68-72, 2019.
Artículo
en Zh
| WPRIM | ID: wpr-810386
11.
Immunocheckpoint inhibition in head and neck squamous cell carcinoma: the current status and progress / 中华肿瘤杂志
Chinese Journal of Oncology
; (12): 641-647, 2019.
Artículo
en Zh
| WPRIM | ID: wpr-797941
12.
Progress of inflammatory cytokines as lymphoma biomarkers and molecular targets / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 501-505, 2019.
Artículo
en Zh
| WPRIM | ID: wpr-751431
13.
The clinical and pathological features, biomarker characteristics and prognosis analysis of lung adenosquamous carcinoma / 中华肿瘤杂志
Chinese Journal of Oncology
; (12): 50-55, 2019.
Artículo
en Zh
| WPRIM | ID: wpr-810383
14.
Clinical research and drug review of epidermal growth factor receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer / 中华肿瘤杂志
Chinese Journal of Oncology
; (12): 949-952, 2019.
Artículo
en Zh
| WPRIM | ID: wpr-800455
15.
Prospect for chimeric antigen receptor-engineered T cell immunotherapy for solid tumors / 中华肿瘤杂志
Chinese Journal of Oncology
; (12): 490-492, 2018.
Artículo
en Zh
| WPRIM | ID: wpr-810069
16.
The efficacy and influence factors analysis of EGFR TKIs on patients with lung adenosquamous carcinoma / 中华肿瘤杂志
Chinese Journal of Oncology
; (12): 776-781, 2018.
Artículo
en Zh
| WPRIM | ID: wpr-807554
17.
Considerations for anti-cancer drug application by single arm trials / 中华肿瘤杂志
Chinese Journal of Oncology
; (12): 58-62, 2018.
Artículo
en Zh
| WPRIM | ID: wpr-809804
18.
Retrospective analysis of the clinical features and prognostic factors of 370 patients with advanced-stage diffuse large B-cell lymphoma / 中华肿瘤杂志
Chinese Journal of Oncology
; (12): 456-461, 2018.
Artículo
en Zh
| WPRIM | ID: wpr-806732
19.
China National Lung Cancer Screening Guideline with Low-dose Computed Tomography (2018 version) / 中国肺癌杂志
Chinese Journal of Lung Cancer
; (12): 67-75, 2018.
Artículo
en Zh
| WPRIM | ID: wpr-776375
20.
The development of biosimilars in oncology / 中华肿瘤杂志
Chinese Journal of Oncology
; (12): 721-725, 2017.
Artículo
en Zh
| WPRIM | ID: wpr-809436